Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Synthetic Biologics, 10 Mar 2014
Accessed on 11 Mar 2014 from http://www.syntheticbiologics.com/2014-03-10-Synthetic-Biologics-Announces-Issuance-of-U-S-Patent-Adding-Another-Layer-of-Protection-for-the-Use-of-Oral-Estriol-Candidate-Trimesta-for-Multiple-Sclerosis.